PAVmed (PAVM) Net Income towards Common Stockholders (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 71.05% |
| Sep 30, 2025 | 52.45% |
| Jun 30, 2025 | -175.21% |
| Mar 31, 2025 | 1,214.64% |
| Jun 30, 2024 | 52.13% |
| Mar 31, 2024 | -43.28% |
| Dec 31, 2023 | 10.38% |
| Sep 30, 2023 | -21.46% |
| Jun 30, 2023 | 18.84% |
| Mar 31, 2023 | 12.31% |
| Dec 31, 2022 | 21.62% |
| Sep 30, 2022 | -2.35% |
| Jun 30, 2022 | -51.09% |
| Mar 31, 2022 | 2.00% |
| Dec 31, 2021 | -40.60% |
| Sep 30, 2021 | -6.49% |
| Jun 30, 2021 | -21.45% |
| Mar 31, 2021 | -7.88% |
| Dec 31, 2020 | -58.57% |
| Sep 30, 2020 | 1.63% |
| Jun 30, 2020 | 61.16% |
| Mar 31, 2020 | -130.40% |
| Dec 31, 2019 | -100.22% |
| Sep 30, 2019 | 13.85% |
| Jun 30, 2019 | -1.67% |
| Mar 31, 2019 | 47.80% |
| Dec 31, 2018 | -108.27% |
| Sep 30, 2018 | 35.44% |
| Jun 30, 2018 | -50.20% |
| Mar 31, 2018 | -1,202.64% |
| Dec 31, 2017 | 105.77% |
| Sep 30, 2017 | -415.89% |
| Jun 30, 2017 | 75.77% |
| Mar 31, 2017 | -151.18% |
| Dec 31, 2016 | 11.31% |
| Sep 30, 2016 | -46.70% |
| Jun 30, 2016 | -88.66% |